Provided by Tiger Trade Technology Pte. Ltd.

MaxCyte Inc

1.38
0.0000
Post-market: 1.380.00000.00%19:30 EDT
Volume:435.91K
Turnover:599.33K
Market Cap:142.42M
PE:-4.13
High:1.40
Open:1.40
Low:1.36
Close:1.38
52wk High:1.87
52wk Low:0.6434
Shares:103.21M
Float Shares:93.72M
Volume Ratio:0.59
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3338
EPS(LYR):-0.4200
ROE:-20.39%
ROA:-10.64%
PB:0.90
PE(LYR):-3.29

Loading ...

Company Profile

Company Name:
MaxCyte Inc
Exchange:
NASDAQ
Establishment Date:
1998
Employees:
91
Office Location:
9713 Key West Avenue,Suite 400,Rockville,Maryland,United States
Zip Code:
20850
Fax:
- -
Introduction:
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Directors

Name
Position
Maher Masoud
President, Chief Executive Officer and Director
Richard H. Douglas
Non-Executive Chairman of the Board
John Johnston
Independent Director
Patrick J Balthrop Sr
Independent Director
Rekha Hemrajani
Independent Director
Stanley C. Erck
Independent Director
Will Brooke
Independent Director
Yasir Al Wakeel
Independent Director
Cynthia Lynne Collins
Director

Shareholders

Name
Position
Maher Masoud
President, Chief Executive Officer and Director
David I. Sandoval
Senior Vice President, General Counsel and Corporate Secretary
Douglas Swirsky
Chief Financial Officer and Principal Accounting Officer